Literature DB >> 19205872

Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer.

Joshua D Bosman1, Fruma Yehiely, Joseph R Evans, Vincent L Cryns.   

Abstract

Recent studies indicate that the small heat shock protein alphaB-crystallin is expressed in poor prognosis basal-like breast tumors and likely contributes to their aggressive phenotype. However, the mechanisms underlying the deregulated expression of alphaB-crystallin in basal-like tumors are poorly understood. Using a bioinformatics approach, we identified a putative DNA binding motif in the human alphaB-crystallin promoter for the proto-oncogene Ets1, a member of the ETS transcription factor family that bind to DNA at palindromic ETS-binding sites (EBS). Here we demonstrate that ectopic expression of Ets1 activates the alphaB-crystallin promoter by an EBS-dependent mechanism and increases alphaB-crystallin protein levels, while silencing Ets1 reduces alphaB-crystallin promoter activity and protein levels. Chromatin immunoprecipitation analyses showed that endogenous Ets1 binds to the alphaB-crystallin promoter in basal-like breast cancer cells in vivo. Interrogation of publically available gene expression data revealed that Ets1 is expressed in human basal-like breast tumors and is associated with poor survival. Collectively, our results point to a previously unrecognized link between the oncogenic transcription factor Ets1 and alphaB-crystallin in basal-like breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205872      PMCID: PMC2791186          DOI: 10.1007/s10549-009-0330-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  36 in total

1.  Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.

Authors:  Paul N Span; Peggy Manders; Joop J Heuvel; Chris M G Thomas; Remko R Bosch; Louk V A M Beex; C G J Sweep
Journal:  Oncogene       Date:  2002-12-05       Impact factor: 9.867

2.  AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.

Authors:  Jose V Moyano; Joseph R Evans; Feng Chen; Meiling Lu; Michael E Werner; Fruma Yehiely; Leslie K Diaz; Dmitry Turbin; Gamze Karaca; Elizabeth Wiley; Torsten O Nielsen; Charles M Perou; Vincent L Cryns
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Gene expression profiling of breast cell lines identifies potential new basal markers.

Authors:  E Charafe-Jauffret; C Ginestier; F Monville; P Finetti; J Adélaïde; N Cervera; S Fekairi; L Xerri; J Jacquemier; D Birnbaum; F Bertucci
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

4.  Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer.

Authors:  David Chin; Glen M Boyle; Rebecca M Williams; Kaltin Ferguson; Nirmala Pandeya; Julie Pedley; Catherine M Campbell; David R Theile; Peter G Parsons; William B Coman
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

Review 5.  Deconstructing the molecular portrait of basal-like breast cancer.

Authors:  Fruma Yehiely; Jose V Moyano; Joseph R Evans; Torsten O Nielsen; Vincent L Cryns
Journal:  Trends Mol Med       Date:  2006-09-29       Impact factor: 11.951

6.  The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3.

Authors:  Merideth C Kamradt; Meiling Lu; Michael E Werner; Toni Kwan; Feng Chen; Anne Strohecker; Shayna Oshita; John C Wilkinson; Chunjiang Yu; Patsy G Oliver; Colin S Duckett; Donald J Buchsbaum; Albert F LoBuglio; V Craig Jordan; Vincent L Cryns
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

Review 7.  ETS transcription factors and their emerging roles in human cancer.

Authors:  Arun Seth; Dennis K Watson
Journal:  Eur J Cancer       Date:  2005-10-06       Impact factor: 9.162

8.  Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth.

Authors:  Jens Claus Hahne; Ali Fuat Okuducu; Annette Kaminski; Alexandra Florin; Fabrice Soncin; Nicolas Wernert
Journal:  Oncogene       Date:  2005-08-11       Impact factor: 9.867

9.  alpha-Crystallin localizes to the leading edges of migrating lens epithelial cells.

Authors:  Rupalatha Maddala; Vasantha P Rao
Journal:  Exp Cell Res       Date:  2005-03-17       Impact factor: 3.905

10.  X chromosomal abnormalities in basal-like human breast cancer.

Authors:  Andrea L Richardson; Zhigang C Wang; Arcangela De Nicolo; Xin Lu; Myles Brown; Alexander Miron; Xiaodong Liao; J Dirk Iglehart; David M Livingston; Shridar Ganesan
Journal:  Cancer Cell       Date:  2006-02       Impact factor: 31.743

View more
  12 in total

1.  Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.

Authors:  Gang Lu; Qing Zhang; Ying Huang; Jiaxi Song; Ross Tomaino; Tobias Ehrenberger; Elgene Lim; Wenbin Liu; Roderick T Bronson; Michaela Bowden; Jane Brock; Ian E Krop; Deborah A Dillon; Steven P Gygi; Gordon B Mills; Andrea L Richardson; Sabina Signoretti; Michael B Yaffe; William G Kaelin
Journal:  Cancer Cell       Date:  2014-08-11       Impact factor: 31.743

2.  AP-2β enhances p53-mediated transcription of the αB-crystallin gene through stabilizing p53.

Authors:  Xiang Hu; Lin Wang; Wei Sun; Ling Xiao; Yuan Wu; Yiming Zhuo; Dongsong Nie; Jianlin Zhou; Jian Zhang
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

3.  MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.

Authors:  Zhiguo Zhu; Lianmin Luo; Qian Xiang; Jiamin Wang; Yangzhou Liu; Yihan Deng; Zhigang Zhao
Journal:  Cell Death Dis       Date:  2020-11-03       Impact factor: 8.469

Review 4.  αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic target.

Authors:  Dmitry Malin; Vladimir Petrovic; Elena Strekalova; Bhawna Sharma; Vincent L Cryns
Journal:  Pharmacol Ther       Date:  2016-01-25       Impact factor: 12.310

5.  αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.

Authors:  Hae Sung Kim; Younok Lee; Young Ah Lim; Hee Joon Kang; Lee Su Kim
Journal:  J Breast Cancer       Date:  2011-03-31       Impact factor: 3.588

6.  The possible functions of duplicated ets (GGAA) motifs located near transcription start sites of various human genes.

Authors:  Fumiaki Uchiumi; Satoru Miyazaki; Sei-ichi Tanuma
Journal:  Cell Mol Life Sci       Date:  2011-04-03       Impact factor: 9.261

7.  alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.

Authors:  Triantafyllia Koletsa; Flora Stavridi; Mattheos Bobos; Ioannis Kostopoulos; Vassiliki Kotoula; Anastasia G Eleftheraki; Irene Konstantopoulou; Christos Papadimitriou; Anna Batistatou; Helen Gogas; Angelos Koutras; Dimosthenis V Skarlos; George Pentheroudakis; Ioannis Efstratiou; Dimitrios Pectasides; George Fountzilas
Journal:  BMC Clin Pathol       Date:  2014-06-23

8.  Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.

Authors:  Christopher H Switzer; Robert Y-S Cheng; Lisa A Ridnour; Sharon A Glynn; Stefan Ambs; David A Wink
Journal:  Breast Cancer Res       Date:  2012-09-12       Impact factor: 6.466

Review 9.  AlphaB-crystallin and breast cancer: role and possible therapeutic strategies.

Authors:  Daniela Caporossi; Attilio Parisi; Cristina Fantini; Elisa Grazioli; Claudia Cerulli; Ivan Dimauro
Journal:  Cell Stress Chaperones       Date:  2020-10-28       Impact factor: 3.667

10.  HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.

Authors:  André-Patrick Arrigo; Benjamin Gibert
Journal:  Cancers (Basel)       Date:  2014-02-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.